Skip to main content
Clinical Trials/NCT06155877
NCT06155877
Completed
Not Applicable

Interventions to Reduce Vaccine Hesitancy Among Adolescents: A Randomized Controlled Trial.

Centre National de la Recherche Scientifique, France1 site in 1 country8,590 target enrollmentNovember 15, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vaccine Hesitancy
Sponsor
Centre National de la Recherche Scientifique, France
Enrollment
8590
Locations
1
Primary Endpoint
Attitude towards vaccination
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Vaccines currently prevent several million deaths every year and more lives could be saved if vaccination take up increased. The World Health Organization identifies vaccine hesitancy as one of the ten most important threats to global health and emphasizes the importance of devising interventions to reduce vaccine hesitancy. The two most promising interventions rely on consensus messaging, which has robust but small effects, and interactive discussion, which has larger effects, but is difficult to scale up. School-based interventions aimed at adolescents have the potential to make the best of both types of interventions. Interventions that take place in schools can be conducted over longer periods of time (up to several hours) and are rolled out by a figure that is typically trusted and respected (the teacher). Moreover, intervening during adolescence is particularly timely since important vaccines are delivered at that age (most notably the human papillomavirus vaccine), and because attitudes towards vaccination during adolescence might have a long-lasting impact, as is the case for other health related attitudes.

This study tests the effectiveness of two interventions, a pedagogical intervention based on consensus messaging, and a chatbot intervention designed to mimic interactive discussion, on 9th grade French pupils.

Registry
clinicaltrials.gov
Start Date
November 15, 2022
End Date
June 23, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Centre National de la Recherche Scientifique, France
Responsible Party
Principal Investigator
Principal Investigator

Hugo Mercier

Research Director

Centre National de la Recherche Scientifique, France

Eligibility Criteria

Inclusion Criteria

  • French 9th grade students (equivalent to "troisième")'
  • One class per school

Exclusion Criteria

  • Do not understand French

Outcomes

Primary Outcomes

Attitude towards vaccination

Time Frame: Up to 8 months

Participants' attitude towards vaccination were measured as the average agreement with 4 questions measured on a 7-points Likert Scale created for this study, ranging from 1 - "Completely disagree" to 7 - "Totally agree", where a higher score corresponds to more positive attitudes towards vaccination. "The vaccines used in France are effective" "The vaccines used in France are safe" "Vaccines are useful because they protect us from dangerous diseases". "It is important to get vaccinated to protect others". For the full questionnaire, see the experiment's OSF repository. All outcomes were assessed three times: before teachers received our interventions (November 15th - December 12th), in the middle of the school year (March 6th -June 8th), and after all teachers used our interventions (May 11th - June 23rd).

Secondary Outcomes

  • Knowledge about vaccination(Up to 8 months)
  • Intention to be vaccinated(Up to 8 months)

Study Sites (1)

Loading locations...

Similar Trials